| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K48477130 | CTRPv2 | pan-cancer | AAC | 0.0038 | 0.9 |
| mRNA | Zebularine | CTRPv2 | pan-cancer | AAC | -0.0023 | 0.9 |
| mRNA | phenformin | GDSC1000 | pan-cancer | AAC | -0.0021 | 0.9 |
| mRNA | selumetinib:GDC-0941 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0022 | 1 |
| mRNA | compound 1B | CTRPv2 | pan-cancer | AAC | -0.0021 | 1 |
| mRNA | BRD-K34099515 | CTRPv2 | pan-cancer | AAC | 0.0046 | 1 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | 0.0025 | 1 |
| mRNA | PLX4720 | GDSC1000 | pan-cancer | AAC | 0.0014 | 1 |
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | 0.0016 | 1 |
| mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | 0.0016 | 1 |